表紙
市場調查報告書

亞太地區的脫髮症治療市場:各治療類型、疾病適應症、終端用戶,及各國 - 市場規模,佔有率,預測,及機會分析

Asia Pacific Alopecia Treatment Market, By Treatment Type, By Disease Indication, By End User, and By Countries - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

出版商 Coherent Market Insights 商品編碼 948397
出版日期 內容資訊 英文 177 Pages
商品交期: 2-3個工作天內
價格
亞太地區的脫髮症治療市場:各治療類型、疾病適應症、終端用戶,及各國 - 市場規模,佔有率,預測,及機會分析 Asia Pacific Alopecia Treatment Market, By Treatment Type, By Disease Indication, By End User, and By Countries - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
出版日期: 2020年07月02日內容資訊: 英文 177 Pages
簡介

圓形脫髮症,是引起非預期的脫髮的一般自體免疫疾病,疤痕性脫髮症,特徵是疤痕的形成伴隨的脫髮狀態。亞太地區的脫髮症治療市場阻礙因素,治療藥的有效性有限,及缺乏證據表明現有的脫髮症治療藥的臨床有效性。

本報告提供亞太地區的脫髮症治療市場的相關調查,市場機會和趨勢,成長及阻礙因素,各治療類型、疾病適應症、終端用戶、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 調查的目的與前提條件

第2章 市場展望

  • 報告的說明
  • 市場定義和範圍
  • 摘要整理
  • 市場明細 :各治療類型
  • 市場明細 :各疾病適應症
  • 市場明細 :各終端用戶
  • Coherent Opportunity Map (COM)

第3章 市場動態,法規,趨勢分析

  • 市場動態
  • 成長要素
  • 阻礙因素
  • 市場機會
  • 影響分析
  • 主要的發展
  • 技術進步
  • 法規方案
  • COVID-19分析的影響

第4章 市場分析:各治療類型

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
  • 外用藥
  • 凝膠
  • 洗髮精
  • 化妝水
  • 泡沫
  • 口服藥
  • 注射
  • 富血小板血漿
  • 類固醇注射
  • 注射式填充物
  • 植毛服務
  • 低等級的雷射治療

第5章 市場分析:各疾病適應症

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
  • 圓形脫髮症
  • 全頭脫髮症
  • 全身性脫髮症

第6章 市場分析:各終端用戶

  • 簡介
  • 市場佔有率分析
  • 與前一年同期比較成長分析
  • 市場區隔趨勢
  • 醫院
  • 皮膚科及毛髮診所
  • 居家照護
  • 審美診所

第7章 市場分析:各國

    • 簡介
    • 市場佔有率分析
    • 與前一年同期比較成長分析
    • 市場區隔趨勢
    • 中國
    • 日本
    • 澳洲
    • 印度
    • 馬來西亞
    • 新加坡
    • 越南
    • 菲律賓
    • 其他國

第8章 競爭情形

  • 企業簡介
  • Teva Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Johnson & Johnson, Inc.
  • Pfizer, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Ltd.
  • Cellmid Ltd.
  • The Himalaya Drug Company
  • 大正製藥株式會社
  • 株式會社資生堂

第9章 Section

    • 參考文件
    • 調查手法
    • 關於本公司
目錄

Title:
Asia Pacific Alopecia Treatment Market, By Treatment Type (Topical Drugs (Creams, Oils, Gels, Shampoo, Lotion, Foam), Oral Drugs, Injectables (Platelet Rich Plasma, Steroid Injections, Injectable Filler), Hair Transplant Services, Low-Level Laser Therapy), By Disease Indication (Alopecia Areata, Alopecia Totalis, Alopecia Universalis), By End User (Hospitals, Dermatologic and Trichology Clinics, Home care settings, Aesthetic Clinics), and By Countries (China, Japan, Australia, New Zealand, Malaysia, India, Singapore, Vietnam, Philippines, Rest of APAC) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027.

Alopecia areata is a common autoimmune disorder that results in unpredictable hair loss. Alopecia is the common autoimmune disorder, which causes hair loss or sometimes it may lead to baldness. Cicatricial alopecia is the condition characterized by hair loss accompanied by the formation of scars. Alopecia is classified into alopecia areata, androgenic alopecia, alopecia totalis, and cicatricial alopecia. In this case, the body attacks its own anagen hair follicles and suppresses or stops hair growth.

Restraints of the Asia Pacific Alopecia Treatment Market

Major factors hampering the growth of the Asia Pacific alopecia treatment market during the forecast period constitutes of limited efficacy and lack of evidences suggesting clinical efficacy of available hair loss drugs.

Key features of the study:

  • This report provides in-depth analysis of the Asia pacific alopecia treatment market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019-2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the Asia pacific alopecia treatment market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Merck & Co., Inc., Johnson & Johnson, Inc., Pfizer, Inc., Dr. Reddy's Laboratories Ltd., Cipla Ltd., Cellmid Ltd., The Himalaya Drug Company, Taisho Pharmaceutical Holdings Co., Ltd., Shiseido Co., Ltd., Concert Pharmaceuticals, Inc., Follica, Inc., REVIAN Inc., Incyte, Eli Lilly and Company, Histogen, Inc., and Zhangguang 101 Science & Technology Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The Asia pacific alopecia treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Asia Pacific Alopecia Treatment Market, By Treatment Type:
  • Topical Drugs
  • Creams
  • Oils
  • Gels
  • Shampoo
  • Lotion
  • Foam
  • Oral Drugs
  • Injectables
  • Platelet Rich Plasma
  • Steroid Injections
  • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • Asia Pacific Alopecia Treatment Market, By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • Asia Pacific Alopecia Treatment Market, By End User:
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Asia Pacific Alopecia Treatment Market, By Countries:
  • China
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Japan
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Australia
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • India
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Malaysia
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Singapore
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Vietnam
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Philippines
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Rest of APAC
  • By Treatment Type
  • Topical Drugs
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
  • Oral Drugs
  • Injectables
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
  • Hair Transplant Services
  • Low-Level Laser Therapy
  • By Disease Indication:
  • Alopecia Areata
  • Alopecia Totalis
  • Alopecia Universalis
  • By End User
  • Hospitals
  • Dermatologic and Trichology Clinics
  • Home care settings
  • Aesthetic Clinics
  • Company Profiles
  • Teva Pharmaceutical Industries Ltd.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Merck & Co., Inc.
  • Johnson & Johnson, Inc.
  • Pfizer, Inc.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Ltd.
  • Cellmid Ltd.
  • The Himalaya Drug Company
  • Taisho Pharmaceutical Holdings Co. Ltd.
  • Shiseido Co., Ltd.
  • Other Major Players

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

    • Research Objectives
    • Assumptions
    • Abbreviations

2. Market Purview

    • Report Description
    • Market Definition and Scope
    • Executive Summary
    • Market Snippet, By Treatment Type
    • Market Snippet, By Disease Indication
    • Market Snippet, By End User
    • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
    • Impact of COVID-19 Analysis

4. Asia Pacific Alopecia Treatment Market, By Treatment Type, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Topical Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Creams
    • Oils
    • Gels
    • Shampoo
    • Lotion
    • Foam
    • Oral Drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Injectables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Platelet Rich Plasma
    • Steroid Injections
    • Injectable Filler
    • Hair Transplant Services
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Low-Level Laser Therapy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

5. Asia Pacific Alopecia Treatment Market, By Disease Indication, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Alopecia Areata
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Alopecia Totalis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Alopecia Universalis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

6. Asia Pacific Alopecia Treatment Market, By End User, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Dermatologic and Trichology Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Home care settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends
    • Aesthetic Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Segment Trends

7. Asia Pacific Alopecia Treatment Market, By Countries, 2017 - 2027 (US$ Mn)

    • Introduction
    • Market Share Analysis, 2019 and 2027 (%)
    • Y-o-Y Growth Analysis, 2019-2027
    • Segment Trends
    • China
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Japan
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Australia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • India
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Malaysia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Singapore
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Vietnam
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Philippines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)
    • Rest of APAC
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019 - 2027, (US$ Mn)

8. Competitive Landscape

    • Company Profiles
    • Teva Pharmaceutical Industries Ltd.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Merck & Co., Inc.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Johnson & Johnson, Inc.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Pfizer, Inc.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Dr. Reddy's Laboratories Ltd.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cipla Ltd.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Cellmid Ltd.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • The Himalaya Drug Company
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Taisho Pharmaceutical Holdings Co. Ltd.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Shiseido Co., Ltd.
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
    • Other Major Players
    • Company Overview
    • Treatment Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

9. Section

    • References
    • Research Methodology
    • About us and Sales Contact